Jared B. Smith, Ph.D., is Principal Scientist in Research and Early Development at REGENXBIO developing gene therapy treatments for diseases of the central nervous system and advancing AAV technology for gene delivery. Prior to joining RGNX in 2019, Dr. Smith was a Research Associate in the Molecular Neurobiology Laboratory at the Salk Institute for Biological Studies in La Jolla, CA and recipient of a K99 Pathway to Independence grant, awarded by the NIH to study the role of the basal ganglia in learning and attention. Dr. Smith received his Ph.D. in systems neuroscience from Penn State College of Medicine, where his research focused on sensory neurophysiology and mapping neural circuitry. He also completed post-doctoral studies in the Center for Neural Engineering at Penn State University, developing advanced methods for non-invasive neuroimaging. He also holds a B.S. in chemistry from Bucknell University.
Dr. Smith’s work has been published in top journals including Nature, Nature Neuroscience, Neuron, Current Biology, eLife, and Journal of Neuroscience. He is a member of the editorial board for numerous journals and has served as a reviewer for numerous peer-reviewed journals and funding agencies. He is also a co-founder and member of the Board of Directors for a non-profit research organization, the Society for Claustrum Research, raising awareness for research into the claustrum, the last brain region with no known function.
